World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
22178
World Ranking
2981
National Ranking
1403

Bernard J. Poiesz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Bernard J. Poiesz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 231 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Bernard J. Poiesz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Bernard J. Poiesz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 63 D-Index — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1993 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Bernard J. Poiesz is affiliated with SUNY Upstate Medical University in the United States and has contributed to research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields, including Molecular Biology, Cardiology and Cardiovascular Medicine, Infectious Diseases, Rheumatology, and Dermatology.

Their research topics cover a range of areas, with a focus on Cardiomyopathy and Myosin Studies, Muscle Physiology and Disorders, Ubiquitin and proteasome pathways, RNA Research and Splicing, RNA and protein synthesis mechanisms, SARS-CoV-2 and COVID-19 Research, and Systemic Lupus Erythematosus Research.

Bernard J. Poiesz has frequently published in the following venues:

  • Cytoskeleton
  • Case Reports in Oncology
  • Clinical Immunology Communications
  • Biochemistry Research International

The scientist has collaborated frequently with several coauthors, including:

  • Dipak K. Dube
  • Syamalima Dube
  • Joseph W. Sanger
  • Jean M. Sanger
  • Lynn Abbott

Selected recent papers authored by Bernard J. Poiesz include:

  • Sarcomeric TPM3 expression in human heart and skeletal muscle, 2020, Cytoskeleton
  • Pfizer-biontech COVID-19 RNA vaccination induces phosphatidylserine autoantibodies, cryoglobulinemia, and digital necrosis in a patient with pre-existing autoimmunity, 2021, Clinical Immunology Communications
  • Inhibitors of the ubiquitin proteasome system block myofibril assembly in cardiomyocytes derived from chick embryos and human pluripotent stem cells, 2021, Cytoskeleton
  • Effect of MG-132 on myofibrillogenesis and the ubiquitination of GAPDH in quail myotubes, 2021, Cytoskeleton
  • Tumor Lysis Syndrome in a Low-Risk Pancreatic Cancer Patient, 2021, Case Reports in Oncology

Bernard J. Poiesz was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 1993.

Best Publications

  • Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

    Bernard J. Poiesz;Francis W. Ruscetti;Adi F. Gazdar;Paul A. Bunn

  • Fidelity of HIV-1 reverse transcriptase

    Bradley D. Preston;Bernard J. Poiesz;Lawrence A. Loeb

  • Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.

    Bernard J. Poiesz;Francis W. Ruscetti;Marvin S. Reitz;V. S. Kalyanaraman

  • Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma

    Y.Q. Huang;J.J. Li;W.C. Zhang;D. Feiner

  • Multiplex detection of four pathogenic retroviruses using molecular beacons

    Jacqueline A. M. Vet;Amit R. Majithia;Salvatore A. E. Marras;Sanjay Tyagi

  • Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection

    S Kwok;D H Mack;K B Mullis;B Poiesz

  • Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line.

    Hyune M. Rho;Bernard Poiesz;Francis W. Ruscetti;Robert C. Gallo

  • T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor

    Bernard J. Poiesz;Francis W. Ruscetti;James W. Mier;Andrea M. Woods

  • Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody.

    Marjorie Robert-Guroff;Francis W. Ruscetti;Lawrence E. Posner;Bernard J. Poiesz

  • Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes.

    Marvin S. Reitz;Bernard J. Poiesz;Francis W. Ruscetti;Robert C. Gallo

  • Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors.

    Alan E. Williams;Chyang T. Fang;Dennis J. Slamon;Bernard J. Poiesz

  • Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy.

    Satyakam Bhagavati;Garth Ehrlich;Roger W. Kula;Shirley Kwok

  • Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses.

    V S Kalyanaraman;M G Sarngadharan;B Poiesz;F W Ruscetti

  • Enzymatic Gene Amplification: Qualitative and Quantitative Methods for Detecting Proviral DNA Amplified in Vitro

    Mark A. Abbott;Bernard J. Poiesz;Bruce C. Byrne;Shirley Kwok

  • Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer

    Stephen L. Graziano;Gary P. Gamble;Nancy B. Newman;Lynn Z. Abbott

  • Herpes zoster: A possible early clinical sign for development of acquired immunodeficiency syndrome in high-risk individuals

    A.E. Friedman-Kien;F.L. Lafleur;E. Gendler;N.P. Hennessey

  • HTLV-I-induced lymphoma mimicking Hodgkin's disease. Diagnosis by polymerase chain reaction amplification of specific HTLV-I sequences in tumor DNA.

    David B. Duggan;Garth D. Ehrlich;Frederick P. Davey;Shirley Kwok

  • Characterization of a Sequence of Human T Cell Leukemia Virus Type I from a Patient with Chronic Progressive Myelopathy

    S. Kwok;D. Kellogg;G. Ehrlich;B. Poiesz

  • Natural antibodies to the human T cell lymphoma virus in patients with cutaneous T cell lymphomas.

    L E Posner;M Robert-Guroff;V S Kalyanaraman;B J Poiesz

  • Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction.

    Garth D. Ehrlich;Jordan B. Glaser;Ken LaVigne;Dianna Quan

Frequent Co-Authors

Garth D. Ehrlich
Garth D. Ehrlich Drexel University
Francis W. Ruscetti
Francis W. Ruscetti National Institutes of Health
Thomas P. Loughran
Thomas P. Loughran University of Virginia
Steven K. H. Foung
Steven K. H. Foung Stanford University
Robert C. Gallo
Robert C. Gallo University of South Florida
Jean M. Sanger
Jean M. Sanger SUNY Upstate Medical University
Stanley A. Schwartz
Stanley A. Schwartz University at Buffalo, State University of New York
William J. Harrington
William J. Harrington University of Miami
Andras Perl
Andras Perl SUNY Upstate Medical University
Richard Yanagihara
Richard Yanagihara University of Hawaii at Manoa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, several related healthcare degrees offer flexible learning opportunities and promising career paths. Exploring the cheapest pmhnp programs online can be a great start for professionals aiming to specialize in psychiatric nursing while maintaining affordability. These programs provide essential skills for managing mental health which often overlaps with immunological conditions.

Advanced nursing roles, such as those requiring a Doctor of Nursing Practice, offer attractive salary prospects. Understanding the dnp salary can help guide decisions around program investment and future earnings, which vary by state and specialization.

Nurses looking to shift focus within acute care settings should consider pursuing acute care np certification. This certification allows Family Nurse Practitioners to expand their expertise into intensive, immunology-relevant care environments.

For those seeking expedited paths, numerous accelerated fnp programs enable quicker entry into Family Nurse Practitioner roles, combining rigorous training with flexible online schedules tailored for busy students and working professionals.

Best Scientists Citing Bernard J. Poiesz

Trending Scientists

Recently Published Articles